Without A Prescription |
| ||
|
RAZEL Crestor |
|
| ||
Home » Prescription Drugs 14 » RAZEL Crestor Lipid lowering agent. (Primary hyper cholesterolaemia). Rosuvastatin is a cholesterol-lowering medication that blocks the production of cholesterol (a type of fat) in the body. It works by reducing levels of "badö cholesterol (low-density lipoprotein or LDL) and triglycerides in the blood while increasing levels of "goodö cholesterol. Rosuvastatin is a member of the statin class; the drugs of first choice for the treatment of dyslipidaemia. Multiple clinical studies have confirmed the effectiveness of Rosuvastatin in reducing LDL-C (æbadÆ cholesterol) and raising HDL-C (ægoodÆ cholesterol). Rosuvastatin is a statin indicated for the treatment of dyslipidaemia. Rosuvastatin is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in your blood. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and therefore the oxygen supply to your heart brain and other parts of your body. Lowering your blood level of cholesterol and fats may help to prevent heart disease angina (chest pain) strokes and heart attacks. Buy RAZEL Crestor and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About RAZEL Crestor: Product Type: Prescription Drugs 14 RAZEL ( Crestor Generic Rosuvastatin ) RAZEL (Crestor Generic Rosuvastatin) Crestor Generic Rosuvastatin 20mg Crestor Generic Rosuvastatin RAZEL
View more Prescription Drugs 14 Without A Prescription: Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests. The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections. Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed. But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.
| ||
